What is Morgan Stanley's price target for LLY?

Morgan Stanley's latest stated price target for Eli Lilly and Company (LLY) is $950, from its action on Feb 16, 2024.

What is Morgan Stanley's rating on LLY?

Morgan Stanley rates LLY Overweight, a bullish rating, as of Feb 16, 2024.

When did Morgan Stanley last change its view on LLY?

On Feb 16, 2024, Morgan Stanley raises its price target to $950 from $805, keeps Overweight.

Morgan Stanley LLY price target and rating history

Eli Lilly and Company (LLY) · Health Care

Morgan Stanley rates Eli Lilly and Company (LLY) Overweight with a $950 price target, as of its latest action on Feb 16, 2024. It has published 6 rating actions on LLY since August 2021, including 0 upgrades and 0 downgrades. Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.

Current rating: Overweight
Price target: $950
Median target, all firms: $1,250
Actions on LLY: 6

Morgan Stanley price target on LLY

Morgan Stanley price target on LLY, each point a stated target, August 2021 to February 2024.

Every Morgan Stanley rating on LLY

Feb 16, 2024
ReiterateMorgan Stanley raises its price target to $950 from $805, keeps Overweight
Apr 6, 2022
ResumeMorgan Stanley resumes coverage at Overweight, price target $265 to $364
Feb 4, 2022
ReiterateMorgan Stanley cuts its price target to $265 from $272, keeps Overweight
Jan 24, 2022
ReiterateMorgan Stanley cuts its price target to $272 from $275, keeps Overweight
Aug 5, 2021
ReiterateMorgan Stanley raises its price target to $275 from $207, keeps Overweight
Aug 4, 2021
ReiterateMorgan Stanley raises its price target to $275 from $207, keeps Overweight

How other firms rate LLY

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Berenberg	Buy	$1,400	Sep 15, 2026
HSBC	Reduce	$850	Mar 17, 2026
RBC Capital Markets	Outperform	$1,250	Feb 25, 2026
Barclays	Overweight	$1,350	Feb 20, 2026
UBS	Buy	$1,250	Jan 7, 2026
Daiwa	Buy	$1,230	Dec 16, 2025
Goldman Sachs	Buy	$1,145	Dec 15, 2025
BofA Securities	Buy	$1,268	Dec 15, 2025

Questions about Morgan Stanley and LLY

What is Morgan Stanley's price target for LLY?: Morgan Stanley's latest stated price target for Eli Lilly and Company (LLY) is $950, from its action on Feb 16, 2024.
What is Morgan Stanley's rating on LLY?: Morgan Stanley rates LLY Overweight, a bullish rating, as of Feb 16, 2024.
When did Morgan Stanley last change its view on LLY?: On Feb 16, 2024, Morgan Stanley raises its price target to $950 from $805, keeps Overweight.
How does Morgan Stanley's LLY target compare with other analysts?: Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.

More LLY rating histories

All Morgan Stanley ratings LLY news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.